drugset

drugset / Trial / NCT02187484

BIBR 277 Capsules in Hypertensive Patients With Nephropathy

NCT02187484 ↗

Phase 2 Completed 23 enrolled Boehringer Ingelheim

NaSingle-groupOpen-labelTreatment

Summary

The antihypertensive effect, safety and usefulness of treatment with BIBR 277 capsules were evaluated in hypertensive patients with nephropathy

Timeline

Start: 1998-08
Primary completion: 1999-08
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Telmisartan	Other / unclassified	—	—

Indications